The report "Endoscopy Equipment Market by Product (Endoscopes (Flexible, Rigid, Robot-assisted, Capsule), Visualization Systems, Accessories, Others), Application (Laparoscopy, Cystoscopy), End User (Hospitals, ASCs, Clinics), and Region - Global Forecast to 2030", is projected to reach USD 53.54 billion by 2030 from USD 37.08 billion in 2025, at a CAGR of 7.6% from 2025 to 2030.
Browse 753 market data Tables and 55 Figures spread through 592 Pages and in-depth TOC on "Endoscopy Equipment Market by Product (Endoscopes (Flexible, Rigid, Robot-assisted, Capsule), Visualization Systems, Accessories, Others), Application (Laparoscopy, Cystoscopy), End User (Hospitals, ASCs, Clinics), and Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/endoscopy-devices-market-689.html
The endoscopy equipment market is witnessing strong growth, driven by rising procedural volumes associated with chronic gastrointestinal, pulmonary, and urological disorders and increasing patient preference for minimally invasive diagnostics. The expansion of day-care endoscopy centers and the shift toward outpatient procedures are further boosting adoption. Future opportunities lie in the development of cost-efficient disposable endoscopes to mitigate infection risks, expanding access in underpenetrated healthcare markets, and leveraging AI-driven analytics and robotics to enhance real-time diagnostics, accuracy, and clinical decision-making across diverse care settings.
Rigid endoscopes product segment to hold second-largest share during forecast period
Based on product, the endoscopy equipment market is segmented into endoscopes, visualization systems, other endoscopy equipment, and accessories. The endoscopes segment is further divided into the rigid endoscopes, flexible endoscopes, robot-assisted endoscopes, and capsule endoscopes. In 2024, rigid endoscopes held a significant market share and are expected to lead during the forecast period. Laparoscopy holds the largest market due to its adoption in minimally invasive surgeries, whereas bronchoscopy is expected to record the fastest growth, driven by the increasing burden of respiratory diseases, particularly lung cancer. Laparoscopy offers significant clinical advantages such as reduced surgical-site infection (SSI) risks, smaller incisions, faster recovery times, and shorter hospital stays compared to open surgeries, making it the preferred choice for patients and physicians.
The growing prevalence of gastrointestinal disorders and urinary system complications has further driven the demand for laparoscopic interventions. Additionally, laparoscopic cholecystectomy, a safe and cost-effective alternative to open gallbladder removal, has gained widespread acceptance, reinforcing the dominance of this segment. Increasing patient preference for minimally invasive procedures, combined with the long-term cost savings and improved clinical outcomes associated with laparoscopic surgeries, has positioned laparoscopes as an indispensable equipment in modern healthcare.
Bronchoscopy application is expected to grow at the fastest rate during the forecast period
The endoscopy equipment market is segmented by application into gastrointestinal endoscopy, bronchoscopy, ENT endoscopy, urology endoscopy (cystoscopy), laparoscopy, obstetrics/gynecology endoscopy, arthroscopy, mediastinoscopy, and other applications.
Among these, the bronchoscopy application is expected to grow at the fastest rate during the forecast period due to the rising global burden of respiratory diseases, particularly lung cancer. According to the American Cancer Society, in 2025, the U.S. alone is expected to witness approximately 226,650 new lung cancer cases and 124,730 related deaths, highlighting the critical need for early detection and continuous monitoring. Bronchoscopes are widely used for diagnostic and therapeutic purposes, including tissue biopsy, airway examination, and interventional procedures such as stent placements or foreign body removal. The growing adoption of minimally invasive techniques, along with video and disposable bronchoscopes, further accelerates segment growth. Additionally, the rising prevalence of chronic respiratory diseases such as COPD, asthma, and infections, along with increasing demand for same-day outpatient bronchoscopy procedures, positions this segment as a key revenue driver in the endoscopy equipment market.
North America to dominate the global endoscopy equipment market during the forecast period
The endoscopy equipment market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America commanded the largest share in 2024, driven by a strong prevalence of chronic diseases, high procedural volumes, and substantial healthcare investments. For instance, according to the American Cancer Society, the U.S. alone reported approximately 2,001,140 new cancer cases and 611,720 cancer-related deaths in 2024, underscoring a significant demand for early diagnostic and therapeutic procedures such as endoscopy.
Furthermore, gastrointestinal disorders remain highly prevalent, with a National Library of Medicine article (May 2025) highlighting that 23.5 million GI endoscopies were performed in 2022. Robust research funding also supports market expansion, with the National Institutes of Health allocating USD 3.6 billion to GI research in 2023, accounting for 7.4% of its total budget. Advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of minimally invasive technologies further strengthen the region’s dominance. Additionally, the presence of leading global manufacturers, coupled with continuous technological innovations such as AI-integrated and disposable endoscopes, enhances accessibility and efficiency, reinforcing North America’s position as the largest revenue-generating region in the global endoscopy equipment market.
Key Players
Some of the prominent players operating in the market include Olympus Corporation (Japan), Karl Storz SE & CO. Kg (Germany), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), HOYA Corporation (Japan), Stryker (US), Medtronic (Ireland), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), Ambu A/S (Denmark), and among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/